CD27 and tuberculosis: In 13 of 22 patients, the percentages of CD27lowIFN-γ+ cells did not decline by the end of 2- mo therapy or declined only slightly to remain above 47% threshold (threshold that in our study discriminated TB patients with severe and mild lung tissue destruction; “CD27-high” group).